Synthetic cannabinoids induce acute lung inflammation via cannabinoid receptor 1 activation

Synthetic cannabinoids (SCs) induce a pro-inflammatory condition by activating cannabinoid receptor 1 (CB(1)R) in the lungs of mice, which raises a potential therapeutic use of CB(1)R antagonists in SC-induced lung disease resulting in hospitalisation https://bit.ly/31bWw4Q

Detalles Bibliográficos
Autores principales: Zawatsky, Charles N., Abdalla, Jasmina, Cinar, Resat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2020
Materias:
Original Research Letters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430153/
https://www.ncbi.nlm.nih.gov/pubmed/32832534
http://dx.doi.org/10.1183/23120541.00121-2020
Descripción
Sumario:Synthetic cannabinoids (SCs) induce a pro-inflammatory condition by activating cannabinoid receptor 1 (CB(1)R) in the lungs of mice, which raises a potential therapeutic use of CB(1)R antagonists in SC-induced lung disease resulting in hospitalisation https://bit.ly/31bWw4Q

Ejemplares similares